Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

LLY

Lilly(Eli) & Co

Feb 07 • 04:00PM ET

878.31

Dollar change +7.94
Percentage change 0.91	%

Healthcare • Drug Manufacturers - General • USA • NYSE

Peers: PFE MRK JNJ BMY GILD AMGN ABBV REGN BIIB VRTX

| Held by: VTI VOO SPY IVV VUG XLV IWF VHT QUAL IVW

Scroll to Statements

Index	S&P 500	P/E	74.96	EPS (ttm)	11.72	Insider Own	10.40%	Shs Outstand	949.32M	Perf Week	8.29%
Market Cap	833.79B	Forward P/E	29.97	EPS next Y	29.31	Insider Trans	-0.27%	Shs Float	848.95M	Perf Month	13.58%
Income	10.59B	PEG	1.85	EPS next Q	4.69	Inst Own	72.67%	Short Float	0.85%	Perf Quarter	8.96%
Sales	45.04B	P/S	18.51	EPS this Y	73.46%	Inst Trans	5.41%	Short Ratio	1.82	Perf Half Y	13.75%
Book/sh	14.99	P/B	58.61	EPS next Y	30.08%	ROA	12.54%	Short Interest	7.22M	Perf Year	24.58%
Cash/sh	3.71	P/C	236.98	EPS next 5Y	40.57%	ROE	65.75%	52W Range	707.02 - 972.53	Perf YTD	13.77%
Dividend Est.	6.73 (0.77%)	P/FCF	595.65	EPS past 5Y	18.77%	ROI	24.47%	52W High	-9.69%	Beta	0.35
Dividend TTM	5.20 (0.59%)	Quick Ratio	0.97	Sales past 5Y	15.54%	Gross Margin	84.46%	52W Low	24.23%	ATR (14)	23.31
Dividend Ex-Date	Feb 14, 2025	Current Ratio	1.27	EPS Y/Y TTM	68.88%	Oper. Margin	37.83%	RSI (14)	71.37	Volatility	3.06% 3.02%
Employees	43000	Debt/Eq	2.19	Sales Y/Y TTM	32.00%	Profit Margin	23.51%	Recom	1.61	Target Price	999.43
Option/Short	Yes / Yes	LT Debt/Eq	2.04	EPS Q/Q	111.70%	Payout	44.39%	Rel Volume	1.07	Prev Close	870.37
Sales Surprise	0.04%	EPS Surprise	6.15%	Sales Q/Q	44.68%	Earnings	Feb 06 BMO	Avg Volume	3.96M	Price	878.31
SMA20	10.48%	SMA50	11.06%	SMA200	4.19%	Trades		Volume	4,227,487	Change	0.91%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-10-24	Resumed	BofA Securities	Buy	$997
Nov-15-24	Initiated	Wolfe Research	Outperform	$1000
Oct-17-24	Initiated	Bernstein	Outperform	$1100
Sep-13-24	Resumed	Citigroup	Buy	$1060
Aug-12-24	Upgrade	Deutsche Bank	Hold → Buy	$1025
Feb-21-24	Downgrade	DZ Bank	Buy → Hold	$820
Feb-16-24	Reiterated	Morgan Stanley	Overweight	$805 → $950
Dec-21-23	Downgrade	Daiwa Securities	Buy → Outperform	$660 → $610
Nov-09-23	Initiated	Deutsche Bank	Hold	$535
Oct-20-23	Resumed	UBS	Buy	$612 → $710
Aug-09-23	Upgrade	Jefferies	Hold → Buy	$408 → $615
Jul-26-23	Reiterated	Citigroup	Buy	$360 → $525
Jul-14-23	Initiated	HSBC Securities	Buy	$560
May-24-23	Reiterated	UBS	Buy	$447 → $498
May-24-23	Reiterated	BofA Securities	Buy	$450 → $500
Mar-13-23	Upgrade	Wells Fargo	Equal Weight → Overweight	$360 → $375
Mar-06-23	Initiated	Jefferies	Hold	$290
Feb-15-23	Downgrade	Societe Generale	Hold → Sell
Nov-18-22	Initiated	Credit Suisse	Outperform	$395
Sep-22-22	Upgrade	UBS	Neutral → Buy	$335 → $363

Show Previous Ratings

Today 01:50PM	Eli Lilly and Company (LLY): Among Ken Fishers Top High Growth Stock Picks (Insider Monkey)
07:10AM	Is Eli Lilly and Company (LLY) the Best Stock to Invest In for Grandchildren? (Insider Monkey)
03:57AM	Down 65%, Is Viking Therapeutics Stock a Buy on the Dip? (Motley Fool)
Feb-07-25 04:42PM	IBD 50 Stock Hims & Hers Faces Backlash Over Provocative Super Bowl Ad (Investor's Business Daily)
07:59AM	Eli Lilly's Recently Approved Inflammatory Bowel Disease Drug Shows Sustained And Durable Treatment At Two Years (Benzinga)
06:45AM	Loading…
06:45AM	Most patients on Lilly's Omvoh (mirikizumab-mrkz) for Crohn's disease achieved sustained clinical remission and endoscopic response at two years (PR Newswire)
05:30AM	The Drug Industry Is Having Its Own DeepSeek Moment (The Wall Street Journal)
05:00AM	Zepbound sales double, tariffs could hit Ozempic, and Pfizer on RFK Jr.: Pharma news roundup (Quartz)
02:37AM	Q4 2024 Eli Lilly and Co Earnings Call (Thomson Reuters StreetEvents)
02:17AM	Eli Lilly and Co (LLY) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ... (GuruFocus.com)
Feb-06-25 06:35PM	Eli Lilly climbs after earnings, top analyst talks what's next for pharma giant (CNBC TV)
04:13PM	Stock Market Today: Dow Jones Dives As Nvidia Rises On DeepSeek Ban Report; Cathie Wood Stock Crashes On Earnings (Live Coverage) (Investor's Business Daily)
04:08PM	Analyst Report: Eli Lilly and Company (Morningstar Research)
04:04PM	Eli Lilly Jumps, Reversing Its Weight-Loss Setback, On A Strong 2025 Outlook (Investor's Business Daily)
04:02PM	Viking Therapeutics Plunged 6% On Its Earnings Report. Here's Why. (Investor's Business Daily)
03:45PM	Loading…
03:45PM	Eli Lilly (LLY) Q4 2024 Earnings Call Transcript (Motley Fool)
02:01PM	Stock Market Today: Indexes Mixed As Nvidia Rises On DeepSeek Ban Report; Cathie Wood Stock Crashes On Earnings (Live Coverage) (Investor's Business Daily)
12:15PM	Viking Therapeutics Plummeted 7% On Its Earnings Report. Here's Why. (Investor's Business Daily)
11:57AM	Meet the 24-year-old helping Lilly test a preventive Alzheimers drug (Fortune)
11:29AM	Why Eli Lilly Stock Popped on Thursday (Motley Fool)
11:27AM	Eli Lilly, Bristol Myers Squibb, Peloton: Market Minute (Yahoo Finance Video)
11:21AM	Eli Lilly Up 13.3% in 2025: Stock Soars as New Breakthroughs Set to Fuel Explosive Growth (GuruFocus.com)
11:16AM	The Obesity Market Is Growing Just Fine. But Investors Want to Know Whats Next (The Wall Street Journal)
11:00AM	Compared to Estimates, Lilly (LLY) Q4 Earnings: A Look at Key Metrics (Zacks)
10:58AM	Zepbound sales keep soaring, even as weight loss drug growth slows (Quartz)
10:11AM	Eli Lilly's Q4 results beat Wall Street estimates (Yahoo Finance Video)
09:56AM	Eli Lillys Disappointing Quarter Was Already Baked In (Barrons.com)
09:22AM	Diabetes and obesity drugs fuel Eli Lilly profit in the final quarter of 2024 (Associated Press Finance)
08:38AM	Eli Lilly reports mixed earnings, increases 2025 guidance (Yahoo Finance)
08:26AM	Heres Why Eli Lilly (LLY) Traded Down in Q4 (Insider Monkey)
08:19AM	Loading…
08:19AM	Eli Lilly Posts Mixed Q4 Results; Fiscal 2025 Guidance Reaffirmed (GuruFocus.com)
08:03AM	5 Things to Know Before the Stock Market Opens (Investopedia)
08:03AM	Mounjaro and Zepbound Sales Soar, Pushing Eli Lilly's (LLY) Q4 Revenue to New Highs (GuruFocus.com)
07:59AM	Eli Lilly Q4 Earnings: Strong Demand For Mounjaro But Prices Dip, Forecasts Over 30% Jump In 2025 Sales On Newer Medicines (Benzinga)
07:33AM	Eli Lilly posts mixed quarter even as demand for weight loss, diabetes drugs soars (CNBC TV)
07:24AM	Eli Lilly Stock Rises After Earnings Beat, Upbeat Guidance (Barrons.com)
07:21AM	Eli Lilly Earnings Top, 2025 Guidance Strong, But Weight-Loss Drug Sales Miss (Investor's Business Daily)
07:11AM	Eli Lilly (NYSE:LLY) Reports Q4 In Line With Expectations, Full-Year Outlook Slightly Exceeds Expectations (StockStory)
07:11AM	Eli Lilly Adjusted Profit Tops Estimates as Weight-Loss Drug Sales Fall Short (Investopedia)
06:55AM	Lilly: Q4 Earnings Snapshot (Associated Press Finance)
06:50AM	Lilly forecasts 2025 profit growth after recent weight-loss drug worries (Reuters)
06:45AM	Lilly reports full Q4 2024 financial results and provides 2025 guidance (PR Newswire)
06:07AM	Stock Market Today: Stocks nudge higher with Amazon earnings on deck (TheStreet)
04:17AM	Eli Lilly (LLY) Stock Eyes Price Breakout as Q4 Results Loom (TipRanks)
Feb-05-25 07:00PM	Amazon earnings, FedSpeak, mortgage rates: What to Watch (Yahoo Finance Video)
04:23PM	Eli Lillys Results Already Disappointed the Street. More Details Come Thursday. (Barrons.com)
01:34PM	What To Expect When Eli Lilly Reports Q4 Earnings On Thursday? (Benzinga)
11:14AM	Novo Nordisk Expects Positive News on Weight-Loss Drugs, Soon, From FDA (Barrons.com)
09:59AM	Steady M&A Deals to Begin 2025, Disappointing IPOs So Far (GuruFocus.com)
08:59AM	Novo Nordisk Outlook Provides Some Welcome Relief (The Wall Street Journal)
08:20AM	Novo Nordisk beats on Wegovy sales, expects slower 2025 growth (Yahoo Finance)
08:16AM	Lillys investigational Alzheimers to be investigated in prevention trial (Clinical Trials Arena)
08:06AM	What To Expect From Eli Lillys (LLY) Q4 Earnings (StockStory)
07:02AM	Novo Nordisk Stock Jumps After Earnings. The Weight-Loss Drugmaker Has Growth Concerns. (Barrons.com)
07:00AM	Merck Is Suffering From a Classic Pharma Problem (The Wall Street Journal)
06:03AM	Lilly needs a plan to spur weight-loss drug sales, investors say (Reuters)
04:43AM	Novo Nordisk Stock Rises After Earnings Beat. There Are Some Growth Concerns. (Barrons.com)
03:08AM	Novo Nordisk Expects Slowing Sales Growth This Year (The Wall Street Journal)
Feb-04-25 02:59PM	Jim Cramer Says Eli Lilly and Company (LLY)s Doing Quite Well (Insider Monkey)
10:27AM	Novartis Sets High Bar in Pursuit of Obesity Deals, CEO Says (The Wall Street Journal)
09:50AM	Pfizer beats Q4, FY '24 earnings estimates, stock flat in early trading (Yahoo Finance)
08:52AM	Pfizer beats Q4, FY '24 earnings estimates, stock flat in premarket trading (Yahoo Finance)
08:52AM	Pfizer beats Q4, FY '24 earnings estimates, stock down slightly in premarket trading (Yahoo Finance)
08:48AM	Aristotle Atlantic Focus Growth Strategy Increased its Holdings in Eli Lilly and Company (LLY) (Insider Monkey)
07:03AM	Investors are growing anxious about Novo Nordisks silence since disappointing CagriSema weight loss drug results (Fortune)
02:40AM	Why Does Jim Cramer Prefer Eli Lilly (LLY) Over Viking Therapeutics? (Insider Monkey)
01:10AM	Investors seek answers on Novo Nordisk's next-gen obesity drug CagriSema (Reuters)
Feb-03-25 01:00PM	What Analysts Think of Eli Lilly Stock Ahead of Earnings (Investopedia)
10:50AM	Jim Cramer Expects Novo Nordisk A/S (NVO) To Forecast A Good 2025 (Insider Monkey)
10:42AM	Jim Cramer on Eli Lilly and Company (LLY): I Remain Steadfast (Insider Monkey)
09:30AM	3 Magnificent Stocks to Buy and Hold Forever (Motley Fool)
09:16AM	Curious about Lilly (LLY) Q4 Performance? Explore Wall Street Estimates for Key Metrics (Zacks)
08:10AM	Why Eli Lilly and Company (LLY) Is the Best Cancer Stock to Buy According to Hedge Funds (Insider Monkey)
Feb-02-25 02:26PM	Eli Lilly (LLY): I Still Like It Cramer Sees Opportunity on the Dip (Insider Monkey)
09:45AM	Forget Wegovy: Novo Nordisk May Have a New Billion-Dollar Weight Loss Drug On Its Hands (Motley Fool)
08:05AM	With Zepbound Not Matching Expectations, Should Investors Give Up on Eli Lilly? (Motley Fool)
07:50AM	Trump tariffs, more Big Tech earnings, and a jobs report: What to know this week (Yahoo Finance)
07:10AM	Why Eli Lilly and Company (LLY) Is Among the Best Long Term Low Risk Stocks to Buy Now (Insider Monkey)
06:36AM	This Weight Loss Stock Could Soar Over 220%, According to Wall Street. Time to Buy? (Motley Fool)
05:00AM	What To Expect in the Markets This Week (Investopedia)
04:38AM	Got $1,000? 2 Top Growth Stocks to Buy Right Now (Motley Fool)
Feb-01-25 02:56PM	Is Eli Lilly and Company (LLY) the Most Promising Dividend Stock According to Hedge Funds? (Insider Monkey)
08:45AM	3 Unstoppable Stocks You Can Buy and Hold for the Rest of Your Life (Motley Fool)
Jan-31-25 05:28PM	Why Eli Lilly and Company (LLY) Is Among the Best Big Name Stocks to Invest in Now? (Insider Monkey)
04:50PM	Eli Lilly CEO Hasnt Bought Company Shares in Years. He Just Bought This Stock. (Barrons.com)
08:55AM	Q2 2025 Resmed Inc Earnings Call (Thomson Reuters StreetEvents)
08:50AM	Do Options Traders Know Something About Lilly (LLY) Stock We Don't? (Zacks)
07:21AM	Jim Cramer on Eli Lilly and Company (LLY) CEO David Ricks: Hes Money Good, So To Speak (Insider Monkey)
06:37AM	Novo Nordisk Shares Have a Long Road Back from 40% Slump (Bloomberg)
04:30AM	Billionaire Philippe Laffont Just Sold Top Artificial Intelligence Stocks Nvidia and AMD and Piled Into 2 Players Dominating Another High-Growth Billion-Dollar Industry (Motley Fool)
02:07AM	Jim Cramer on Eli Lilly and Company (LLY): Its About The Scripts, Not About The Pill (Insider Monkey)
Jan-30-25 03:00PM	Jim Cramer on Novo Nordisk A/S (NVO): They Dont Have The Production Capability (Insider Monkey)
12:16PM	Jim Cramer Defends Eli Lilly and Company (LLY) Amid Concerns Over Drug Adherence, Cites Long-Term Health Potential (Insider Monkey)
10:01AM	Eli Lilly (LLY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Jan-29-25 11:01AM	Jim Cramer Says Novo Nordisk A/S (NVO) Is Down So Much (Insider Monkey)
09:08AM	Is Eli Lilly and Company (LLY) the Best Stock to Buy in 2025 for Beginners? (Insider Monkey)
07:00AM	Are Weight-Loss Drugs Like Gym Memberships? The Answer Is Worth Billions (The Wall Street Journal)
06:30AM	FDA clears use of Ozempic to protect kidney health (BioPharma Dive)
Jan-28-25 05:45PM	Eli Lilly (LLY) Stock Drops Despite Market Gains: Important Facts to Note (Zacks)
03:00PM	Drugmakers Show Restraint on Price Increases in New Trump Era (The Wall Street Journal)

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
LILLY ENDOWMENT INC	10% Owner	Feb 06 '25	Sale	874.13	210,000	183,567,262	96,681,978	Feb 07 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 06 '25	Proposed Sale	842.18	210,000	176,857,800		Feb 06 04:04 PM
Yuffa Ilya	EVP & President, LLY Int'l	Feb 01 '25	Option Exercise	0.00	3,269	0	23,071	Feb 04 04:28 PM
White Anne E.	EVP & Pres, Lilly Neuroscience	Feb 01 '25	Option Exercise	0.00	3,269	0	68,838	Feb 04 04:27 PM
Van Naarden Jacob	EVP & Pres., Lilly Oncology	Feb 01 '25	Option Exercise	0.00	3,023	0	14,868	Feb 04 04:26 PM
Skovronsky Daniel	EVP, CSO & Pres. LRL & LLY Imm	Feb 01 '25	Option Exercise	0.00	8,989	0	126,892	Feb 04 04:25 PM
Ricks David A	President, Chair, and CEO	Feb 01 '25	Option Exercise	0.00	26,561	0	496,385	Feb 04 04:24 PM
Rau Diogo	EVP & CIDO	Feb 01 '25	Option Exercise	0.00	3,269	0	14,370	Feb 04 04:23 PM
Jonsson Patrik	EVP&Pres, CardMetHlth, LLY USA	Feb 01 '25	Option Exercise	0.00	3,433	0	48,016	Feb 04 04:23 PM
Hernandez Edgardo	EVP & Pres., Mfg. Operations	Feb 01 '25	Option Exercise	0.00	2,861	0	33,479	Feb 04 04:21 PM
Hakim Anat	EVP, GC & Secretary	Feb 01 '25	Option Exercise	0.00	4,904	0	20,683	Feb 04 04:19 PM
Zakrowski Donald A	Officer	Nov 08 '24	Proposed Sale	803.38	900	723,042		Nov 08 04:54 PM
Zakrowski Donald A	SVP, Finance, & CAO	Nov 08 '24	Sale	803.38	900	723,042	5,480	Nov 08 04:18 PM
Montarce Lucas	EVP & CFO	Nov 01 '24	Option Exercise	0.00	1,074	0	11,541	Nov 05 04:15 PM
Hernandez Edgardo	EVP & Pres., Mfg. Operations	Nov 01 '24	Option Exercise	0.00	1,687	0	31,369	Nov 05 04:14 PM
Dozier Eric	EVP, HR & Diversity	Nov 01 '24	Option Exercise	0.00	1,534	0	8,724	Nov 05 04:13 PM
LILLY ENDOWMENT INC	10% Owner	Sep 03 '24	Sale	966.69	24,084	23,281,840	96,891,978	Sep 04 04:05 PM
LILLY ENDOWMENT INC	10% Owner	Aug 27 '24	Sale	968.46	24,552	23,777,668	96,916,062	Aug 28 04:05 PM
Zakrowski Donald A	Officer	Aug 26 '24	Proposed Sale	950.00	750	712,500		Aug 26 04:47 PM
Zakrowski Donald A	SVP, Finance, & CAO	Aug 26 '24	Sale	950.00	750	712,500	6,380	Aug 26 04:21 PM
LILLY ENDOWMENT INC	10% Owner	Aug 22 '24	Sale	966.33	3,196	3,088,382	96,940,614	Aug 23 04:05 PM
LILLY ENDOWMENT INC	10% Owner	Aug 22 '24	Proposed Sale	951.97	215,000	204,673,550		Aug 22 12:54 PM
LILLY ENDOWMENT INC	10% Owner	Jul 10 '24	Sale	939.82	210,000	197,361,398	96,943,810	Jul 11 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jul 08 '24	Sale	918.64	93,593	85,977,954	97,153,810	Jul 09 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jul 05 '24	Sale	915.18	52,369	47,927,194	97,247,403	Jul 08 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jul 03 '24	Sale	915.31	8,848	8,098,655	97,299,772	Jul 03 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jul 01 '24	Sale	915.26	58,749	53,770,776	97,308,620	Jul 02 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jun 28 '24	Sale	915.02	1,441	1,318,545	97,367,369	Jul 01 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jun 25 '24	Sale	903.82	188,100	170,009,262	97,368,810	Jun 26 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jun 24 '24	Sale	902.38	17,229	15,547,068	97,556,910	Jun 25 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jun 20 '24	Sale	902.67	9,671	8,729,733	97,574,139	Jun 21 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jun 17 '24	Sale	885.91	194,978	172,733,708	97,583,810	Jun 18 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jun 14 '24	Sale	882.47	15,022	13,256,490	97,778,788	Jun 17 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jun 10 '24	Sale	860.78	75,510	64,997,274	97,793,810	Jun 11 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jun 07 '24	Sale	852.29	139,490	118,886,587	97,869,320	Jun 10 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jun 06 '24	Sale	837.82	179,617	150,485,878	98,008,810	Jun 07 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jun 05 '24	Sale	836.32	20,383	17,046,673	98,188,427	Jun 06 04:00 PM
Rau Diogo	EVP & CIDO	Jun 01 '24	Option Exercise	0.00	6,300	0	14,146	Jun 04 04:14 PM
LILLY ENDOWMENT INC	10% Owner	Jun 03 '24	Sale	829.77	192,794	159,974,050	98,208,810	Jun 04 04:00 PM
Zakrowski Donald A	SVP, Finance, & CAO	Jun 03 '24	Sale	819.47	750	614,602	7,130	Jun 03 04:15 PM
Norton Johna	EVP, Global Quality	Jun 03 '24	Sale	819.38	7,056	5,781,545	25,428	Jun 03 04:14 PM
LILLY ENDOWMENT INC	10% Owner	May 31 '24	Sale	822.11	22,206	18,255,871	98,401,604	Jun 03 04:00 PM
LILLY ENDOWMENT INC	10% Owner	May 29 '24	Sale	811.04	130,385	105,747,975	98,423,810	May 30 04:00 PM
LILLY ENDOWMENT INC	10% Owner	May 28 '24	Sale	809.00	2,052	1,660,068	98,554,195	May 29 04:00 PM
LILLY ENDOWMENT INC	10% Owner	May 24 '24	Sale	809.21	92,563	74,902,998	98,556,247	May 28 04:00 PM
LILLY ENDOWMENT INC	10% Owner	May 23 '24	Sale	809.99	50,767	41,120,963	98,648,810	May 24 04:00 PM
LILLY ENDOWMENT INC	10% Owner	May 22 '24	Sale	804.18	12,974	10,433,483	98,699,577	May 23 04:00 PM
LILLY ENDOWMENT INC	10% Owner	May 21 '24	Sale	805.45	186,259	150,021,694	98,712,551	May 22 04:00 PM
Zakrowski Donald A	SVP, Finance, & CAO	Mar 11 '24	Sale	753.60	750	565,200	7,880	Mar 11 04:27 PM
LILLY ENDOWMENT INC	10% Owner	Feb 16 '24	Sale	780.99	169,684	132,521,930	98,898,810	Feb 20 04:05 PM
LILLY ENDOWMENT INC	10% Owner	Feb 15 '24	Sale	760.46	50,316	38,263,417	99,068,494	Feb 16 04:05 PM
LILLY ENDOWMENT INC	10% Owner	Feb 09 '24	Sale	740.60	206,257	152,753,428	99,118,810	Feb 12 04:05 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

LLY

Lilly(Eli) & Co

Upgrade your FINVIZ experience